| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 6.1% stake in Clever Leaves Holdings Inc. |
| 02/07/2023 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.4% stake in Metals Acquisition Corp |
| 02/07/2023 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 8.7% stake in SDCL EDGE Acquisition Corporation |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/16/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/23/2022 |
SC 13G
| FARALLON CAPITAL MANAGEMENT LLC reports a 5.4% stake in Amyris, Inc. |
| 02/14/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.7% stake in Swiftmerge Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 10% stake in Clever Leaves Holdings Inc. |
| 02/14/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.3% stake in Metals Acquisition Corp |
| 02/11/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 6.9% stake in Protagonist Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 0% stake in Solid Power, Inc. |
| 02/11/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 7.7% stake in Enanta Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 4.9% stake in Caribou Biosciences, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 5.7% stake in Better Therapeutics, Inc. |
| 02/09/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.6% stake in Mercury Ecommerce Acquisition Corp. |
| 02/09/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 7.4% stake in Shelter Acquisition Corporation I |
| 02/09/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 5.8% stake in Inflection Point Acquisition Corp. |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 8.7% stake in SDCL EDGE Acquisition Corporation |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 10% stake in Savara Inc. |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 0% stake in Progenics Pharmaceuticals, Inc. |
| 02/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.6% stake in Marblegate Acquisition Corp. |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 0% stake in BioAtla, Inc. |
| 02/08/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 7% stake in Aramark |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 6.2% stake in Generation Bio Co. |
| 02/03/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 7.4% stake in Imago BioSciences, Inc. |
| 02/03/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 4.9% stake in Broadmark Realty Capital Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 5.2% stake in Big Sky Growth Partners, Inc. |
| 01/27/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 5.2% stake in ARYA Sciences Acquisition Corp IV |
| 01/27/2022 |
SC 13G/A
| FARALLON CAPITAL MANAGEMENT LLC reports a 9.6% stake in Berenson Acquisition Corp. I |
|